12:00 AM
Nov 15, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zenhale regulatory update

The European Medicines Agency (EMA) said Merck withdrew an MAA for Zenhale mometasone/formoterol inhalation aerosol as long-term maintenance to treat asthma in patients 12 years and older....

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >